Targeting the mTOR Pathway for the Prevention of ER-Negative Breast Cancer

Prevention of estrogen receptor (ER)-positive breast cancer is now possible using anti-estrogen drugs; however, this treatment is ineffective against ER-negative breast cancers. In this study, we hypothesized that inhibition of mTOR will suppress the growth of ER-negative and triple-negative breast...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazumdar, Abhijit, Tahaney, William M., Hill, Jamal L., Zhang, Yun, Ramachandran, Sumankalai, Kawedia, Jitesh, Qian, Jing, Contreras, Alejandro, Savage, Michelle I., Vornik, Lana A., Sei, Shizuko, Mohammed, Altaf, Brown, Powel H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762336/
https://www.ncbi.nlm.nih.gov/pubmed/35981902
http://dx.doi.org/10.1158/1940-6207.CAPR-22-0106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762336/
https://www.ncbi.nlm.nih.gov/pubmed/35981902
http://dx.doi.org/10.1158/1940-6207.CAPR-22-0106

Ejemplares similares